Loading...
Centene Corporation
CNC•NYSE
Healthcare
Medical - Healthcare Plans
$28.39
$1.63(6.09%)
Centene Corporation (CNC) Financial Performance & Income Statement Overview
Review Centene Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.89%
↑ 5.89%
Operating Income Growth
8.36%
↑ 8.36%
Net Income Growth
22.32%
↑ 22.32%
Operating Cash Flow Growth
-98.09%
↓ 98.09%
Operating Margin
2.13%
↑ 2.13%
Gross Margin
10.27%
↑ 10.27%
Net Profit Margin
2.04%
↑ 2.04%
ROE
12.67%
↑ 12.67%
ROIC
7.22%
↑ 7.22%
Centene Corporation (CNC) Income Statement & Financial Overview
Review Centene Corporation's (CNC) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $46.62B | $40.80B | $42.02B | $39.84B |
| Cost of Revenue | $41.42B | $37.09B | $37.99B | $35.41B |
| Gross Profit | $5.20B | $3.72B | $4.04B | $4.43B |
| Gross Profit Ratio | $0.11 | $0.09 | $0.10 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.35B | $3.23B | $3.06B | $2.89B |
| Operating Expenses | $3.67B | $3.54B | $3.37B | $3.20B |
| Total Costs & Expenses | $45.09B | $40.63B | $41.36B | $38.61B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $170.00M | $172.00M | $176.00M | $176.00M |
| Depreciation & Amortization | $315.00M | $314.00M | $313.00M | $306.00M |
| EBITDA | $2.23B | $833.00M | $1.41B | $2.00B |
| EBITDA Ratio | $0.05 | $0.02 | $0.03 | $0.05 |
| Operating Income | $1.53B | $175.00M | $665.00M | $1.23B |
| Operating Income Ratio | $0.03 | $0.004 | $0.02 | $0.03 |
| Other Income/Expenses (Net) | $212.00M | $172.00M | $256.00M | $287.00M |
| Income Before Tax | $1.75B | $347.00M | $921.00M | $1.52B |
| Income Before Tax Ratio | $0.04 | $0.009 | $0.02 | $0.04 |
| Income Tax Expense | $432.00M | $67.00M | $211.00M | $370.00M |
| Net Income | $1.31B | $283.00M | $713.00M | $1.15B |
| Net Income Ratio | $0.03 | $0.007 | $0.02 | $0.03 |
| EPS | $2.64 | $0.57 | $1.37 | $2.16 |
| Diluted EPS | $2.63 | $0.56 | $1.36 | $2.16 |
| Weighted Avg Shares Outstanding | $496.21M | $500.42M | $521.97M | $529.60M |
| Weighted Avg Shares Outstanding (Diluted) | $498.18M | $501.98M | $523.54M | $530.75M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan